{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:42:21Z","timestamp":1790664141942,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.metabol.2026.156675","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T22:00:04Z","timestamp":1781474404000},"page":"156675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rethinking hypercortisolism screening in obesity and diabetes: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"182","author":[{"given":"Davide","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tenuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathya","family":"Al Awadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Frookh","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.metabol.2026.156675_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"10.1016\/j.metabol.2026.156675_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.metabol.2026.156675_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1009905808033","article-title":"Cushing's syndrome: historical aspects","volume":"3","author":"Lindholm","year":"2000","journal-title":"Pituitary"},{"issue":"10418","key":"10.1016\/j.metabol.2026.156675_bb0020","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing\u2019s syndrome","volume":"402","author":"Gadelha","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.metabol.2026.156675_bb0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.metabol.2026.156675_bb0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","article-title":"The immune system in Cushing\u2019s syndrome","volume":"31","author":"Hasenmajer","year":"2020","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156675_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The hypertension of Cushing\u2019s syndrome: controversies in the pathophysiology and focus on cardiovascular complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2026.156675_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.747549","article-title":"A new clinical model to estimate the pre-test probability of Cushing\u2019s syndrome: the Cushing score","volume":"12","author":"Parasiliti-Caprino","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"10.1016\/j.metabol.2026.156675_bb0045","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s40618-023-02091-7","article-title":"Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations","volume":"46","author":"De Alcubierre","year":"2023","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"10.1016\/j.metabol.2026.156675_bb0050","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12020-024-03856-7","article-title":"Cardiac magnetic resonance reveals biventricular impairment in Cushing\u2019s syndrome: a multicentre case-control study","volume":"85","author":"Feola","year":"2024","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.metabol.2026.156675_bb0055","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.metabol.2026.156675_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020673","article-title":"Pathophysiology of mild Hypercortisolism: from the bench to the bedside","volume":"23","author":"Favero","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.metabol.2026.156675_bb0065","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.metabol.2026.156675_bb0070","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.metabol.2026.156675_bb0075","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.metabol.2026.156675_bb0080","author":"GRADE"},{"issue":"6","key":"10.1016\/j.metabol.2026.156675_bb0085","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/aje\/kwae332","article-title":"Assessing the certainty of the evidence in systematic reviews: importance, process, and use","volume":"194","author":"Brignardello-Petersen","year":"2025","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156675_bb0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4158\/EP10368.OR","article-title":"Health care resource use and costs among patients with Cushing disease","volume":"17","author":"Swearingen","year":"2011","journal-title":"Endocr Pract"},{"issue":"10365","key":"10.1016\/j.metabol.2026.156675_bb0095","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.metabol.2026.156675_bb0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.metabol.2026.156675_bb0105","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41366-024-01598-0","article-title":"Cushing\u2019s syndrome screening with the 1-mg dexamethasone suppression test in metabolically healthy and unhealthy obesity phenotypes","volume":"48","author":"Hepsen","year":"2024","journal-title":"Int J Obes"},{"issue":"9","key":"10.1016\/j.metabol.2026.156675_bb0110","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgac379","article-title":"Whom should we screen for Cushing syndrome? the Endocrine Society practice guideline recommendations 2008 revisited","volume":"107","author":"Braun","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156675_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-19-0666","article-title":"Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis","volume":"182","author":"van Hulsteijn","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.metabol.2026.156675_bb0120","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-024-00984-y","article-title":"Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches","volume":"20","author":"Prete","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156675_bb0125","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2337\/db25-0120","article-title":"Cushing syndrome, hypercortisolism, and glucose homeostasis: a review","volume":"74","author":"DeFronzo","year":"2025","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.metabol.2026.156675_bb0130","doi-asserted-by":"crossref","DOI":"10.2337\/dbi25-0035","article-title":"Beyond the classical Axis: the adrenal gland under metabolic pressure","volume":"74","author":"Isidori","year":"2025","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.metabol.2026.156675_bb0135","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc24-2841","article-title":"Prevalence of Hypercortisolism in difficult-to-control type 2 diabetes","volume":"48","author":"Buse","year":"2025","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.metabol.2026.156675_bb0140","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.metabol.2026.156675_bb0145","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1210\/jc.2016-1673","article-title":"A probabilistic model for Cushing\u2019s syndrome screening in at-risk populations: a prospective multicenter study","volume":"101","author":"Le\u00f3n-Justel","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2026.156675_bb0150","first-page":"47","article-title":"Who and how to screen for endogenous hypercortisolism in type 2 diabetes mellitus or obesity","volume":"48","author":"Guarnotta","year":"2025","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"10.1016\/j.metabol.2026.156675_bb0155","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-16-0434","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysis","volume":"175","author":"Steffensen","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156675_bb0160","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.eprac.2021.07.014","article-title":"When to suspect hidden Hypercortisolism in type 2 diabetes: a Meta-analysis","volume":"27","author":"Aresta","year":"2021","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.metabol.2026.156675_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2026.102596","article-title":"Investigating endogenous hypercortisolism prevalence in a U.S. population with resistant hypertension","volume":"5","author":"Plutzky","year":"2026","journal-title":"JACC Adv"},{"key":"10.1016\/j.metabol.2026.156675_bb0170","author":"Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session"},{"issue":"4","key":"10.1016\/j.metabol.2026.156675_bb0175","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","article-title":"Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis","volume":"189","author":"Pelsma","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2026.156675_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.898084","article-title":"Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: results of a RCT","volume":"13","author":"Morelli","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.metabol.2026.156675_bb0185","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S2213-8587(25)00062-2","article-title":"Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial","volume":"13","author":"Tabarin","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.metabol.2026.156675_bb0190","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1210\/jc.2017-00823","article-title":"Resetting the abnormal circadian cortisol rhythm in adrenal Incidentaloma patients with mild autonomous cortisol secretion","volume":"102","author":"Debono","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156675_bb0195","article-title":"Overnight Metyrapone therapy in patients with mild autonomous cortisol secretion (MACS): an open label phase 2 interventional study","volume":"8","author":"Ferreira","year":"2024","journal-title":"Journal of the Endocrine Society"},{"issue":"3","key":"10.1016\/j.metabol.2026.156675_bb0200","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ando.2018.04.017","article-title":"The difficulties of pseudo-Cushing\u2019s syndrome (or \u201cnon-neoplastic hypercortisolism\u201d)","volume":"79","author":"Chabre","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"issue":"12","key":"10.1016\/j.metabol.2026.156675_bb0205","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2337\/dc25-1055","article-title":"Inadequately controlled type 2 diabetes and hypercortisolism: improved glycemia with mifepristone treatment","volume":"48","author":"RA","year":"2025","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.metabol.2026.156675_bb0210","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2012-1323","article-title":"Screening of Cushing\u2019s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy","volume":"97","author":"Terzolo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.metabol.2026.156675_bb0215","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2337\/diacare.14.12.1132","article-title":"Metabolic implications of body fat distribution","volume":"14","author":"Bjorntorp","year":"1991","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.metabol.2026.156675_bb0220","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"Efficacy and safety of osilodrostat in patients with Cushing\u2019s disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2026.156675_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.662865","article-title":"Relacorilant, a selective glucocorticoid receptor modulator, induces clinical improvements in patients with Cushing syndrome: results from a prospective, open-label phase 2 study","volume":"12","author":"Pivonello","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.metabol.2026.156675_bb0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-8587(25)00362-6","article-title":"Efficacy and safety of relacorilant for the treatment of patients with Cushing\u2019s syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study","volume":"14","author":"Pivonello","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156675_bb0235","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/clinem\/dgaf206","article-title":"Chronotherapy with once-daily Osilodrostat improves cortisol rhythm, quality of life, and sleep in Cushing\u2019s syndrome","volume":"110","author":"Ferrari","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156675_bb0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4158\/EP14126.OR","article-title":"Burden of illness, annual healthcare utilization, and costs associated with commercially insured patients with Cushing disease in the United States","volume":"21","author":"Broder","year":"2015","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.metabol.2026.156675_bb0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11102-015-0695-9","article-title":"Algorithm development and the clinical and economic burden of Cushing\u2019s disease in a large US health plan database","volume":"19","author":"Burton","year":"2016","journal-title":"Pituitary"},{"issue":"7","key":"10.1016\/j.metabol.2026.156675_bb0250","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0027","article-title":"Unmet needs in Cushing\u2019s syndrome: the patients\u2019 perspective","volume":"11","author":"Valassi","year":"2022","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.metabol.2026.156675_bb0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ejendo\/lvac016","article-title":"Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation","volume":"188","author":"Braun","year":"2023","journal-title":"Eur J Endocrinol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952600185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952600185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:52:00Z","timestamp":1785873120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952600185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"alternative-id":["S002604952600185X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156675","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking hypercortisolism screening in obesity and diabetes: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156675"}}